京威股份(002662.SZ):寧波福爾達及其一致行動人累計減持6.8%股份
格隆匯5月26日丨京威股份(002662.SZ)公佈,公司持股5%以上的股東寧波福爾達投資控股有限公司(“寧波福爾達”)及其一致行動人龔福根、龔斌在2018年9月14日至2020年5月21期間通過大宗交易及集中競價交易方式累計減持公司股份約1.02億股,減持數量佔公司總股本的6.80%。
此次權益變動前,信息披露義務人及其一致行動人合計持有公司股份約2.32億股,佔公司總股本的15.48%,此次權益變動後,合計持有公司股份約1.3億股,佔公司總股本的8.67%,變動比例合計超過5.00%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.